Recent Publications by Biopharm: |
Progress towards personalized medicine.
Personalized medicine is the tailoring of therapies to defined subsets of... | 17th November, 2009
| Biopharm R&D, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage,
| Drug Discov Today. 2009 Nov 12.
DOI Direct Link |
Pharmacokinetic screening strategy for discovery work-use of rodent species: lessons learnt and probing newer thoughts.
Recent published evidences on ibuprofen and meloxicam confirm the need of... | 3rd November, 2009
| Integrated Drug Development Suramus Biopharm, Bangalore, India.
| Drug Metab Pharmacokinet. 2009;24(2):197-8.
|
Composition and molecular size of Clostridium botulinum Type A toxin-hemagglutinin complex.
Bioanalytical assay validation for plethora of parameters is considered... | 21st October, 2009
| Biologicals Science and Technology, Ipsen Biopharm Limited, Wrexham
| Protein J. 2009 Jun;28(5):248-9; discussion 250-1.
DOI Direct Link |
Thermal stability and conformational structure of salmon calcitonin in the solid and liquid states.
Salmon calcitonin (sCT) was selected as a model protein drug for... | 8th October, 2009
| Lab. Pharm. Biopharm., Department of Biotechnology, Yuanpei University,
| Biopolymers. 2009 Oct 6.
DOI Direct Link |
Antacid use and reduced bioavailability of oral drugs. Case studies, overview and perspectives.
A close scrutiny of deployment of the present day home medicines has shown... | 30th September, 2009
| Integrated Drug Development, Suramus Biopharm, Bangalore, India.
| Arzneimittelforschung. 2009;59(7):327-34.
|
Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.
In recent years, the assessment of metabolite pharmacokinetic data has... | 15th September, 2009
| Integrated Drug Development, Suramus Biopharm, Bangalore, India.
| Arzneimittelforschung. 2009;59(4):155-65.
|
Application of Slicing of One-Dimensional Gels with Subsequent Slice-by-Slice Mass Spectrometry for the Proteomic Profiling of Human Liver Cytochromes P450.
Sequential thin slicing of one-dimensional electrophoresis gels followed... | 3rd September, 2009
| Institute of Biomedical Chemistry, Russian Academy of Medical Sciences,
| J Proteome Res. 2009 Sep 22.
DOI Direct Link |
Thermodynamic investigations of nitroxoline sublimation by simultaneous DSC-FTIR method and isothermal TG analysis.
To investigate the physicochemical characteristics, thermodynamics,... | 17th June, 2009
| Lab. Pharm. Biopharm., Department of Biotechnology, Yuanpei University,
| J Pharm Sci. 2009 Jun 15.
DOI Direct Link |
Rationale for faster oral delivery to overcome the pathophysiology associated with dental pain--biopharmaceutic and pharmacokinetic challenges.
Recent published evidences on ibuprofen and meloxicam confirm the need of... | 13th June, 2009
| Integrated Drug Development, Suramus Biopharm, J.P. Nagar, I Phase,
| Eur J Drug Metab Pharmacokinet. 2009 Jan-Mar;34(1):7-10.
|
Is there a place for drug combination strategies using clinical pharmacology attributes?--review of current trends in research.
Drug discovery is the main flag ship of the pharmaceutical industry in... | 9th June, 2009
| Integrated Drug Development, Suramus Biopharm, 77, 10th Cross, 29th Main,
| Curr Clin Pharmacol. 2009 Sep;4(3):220-8. Epub 2009 Sep 1.
|
Allometric Modeling of Ciclesonide, a Nonhalogenated Glucocorticoid, and Its Active Metabolite, Desisobutyrylciclesonide, Using Animal-Derived Pharmacokinetic Parameters.
Ciclesonide, a novel glucocorticosteroid, through a rapid metabolism to... | 7th May, 2009
| From Integrated Drug Development, Suramus Biopharm, J. P. Nagar I Phase,
| Am J Ther. 2009 May 15.
DOI Direct Link |
Bioanalytical assay validation parameters re-visited: perspectives on stability studies.
Bioanalytical assay validation for plethora of parameters is considered... | 30th April, 2009
| Integrated Drug Development, Suramus Biopharm, 77, 10th Cross, 29th Main,
| Biomed Chromatogr. 2009 Oct;23(10):1031-3.
DOI Direct Link |
Dysport: pharmacological properties and factors that influence toxin action.
The pharmacological properties of Dysport that influence toxin action are... | 1st April, 2009
| Biologicals Science and Technology, Ipsen Biopharm Limited, Wrexham, UK.
| Toxicon. 2009 Oct;54(5):683-9. Epub 2009 Mar 28.
DOI Direct Link |
Application of allometry principles for the prediction of human pharmacokinetic parameters for irbesartan, a AT1 receptor antagonist, from animal data.
Allometric principles have been applied to scale and predict human... | 24th March, 2009
| Integrated Drug Development, Suramus Biopharm, J.P. Nagar I Phase,
| Eur J Drug Metab Pharmacokinet. 2008 Oct-Dec;33(4):247-52.
|
